More Exclusive Features

Week in Review: Marijuana vs. alcohol, CA’s lagging cannabis tax revenue & Utah MMJ ally

State-legal cannabis users consume less liquor and medications, according to a report, California isn’t fetching as much marijuana tax revenue as anticipated, and Utah’s MMJ campaign gains a key supporter. Here’s a closer look at some notable developments in the cannabis industry over the past week. Untapped market A study showing that recreational cannabis consumers […]

Read More

Marijuana cultivators find ways to shorten curing process

In an ideal world, cultivators would have the luxury of time when it comes to drying and curing their cannabis.

They’d take 30-60 days – waiting, sniffing, eyeing and “burping” – to achieve the ideal cannabinoid and terpene profile for each lovingly grown flower.

But in the real business world, larger cultivators need to get product out the door. They don’t have one or two months to spend on curing.

That doesn’t mean, however, that cultivators must sacrifice quality for large-scale commercial production.

Read More

How India can become a global cannabis leader: Q&A with Bombay Hemp’s Avnish Pandya

India’s medical marijuana industry will blossom if companies use science to convince regulators that MMJ is an effective medicine. That’s the view of the country’s only licensed medical cannabis cultivator. Avnish Pandya, co-founder of Bombay Hemp Company, said the best way to develop India’s medical marijuana industry is for companies to work with regulators to […]

Read More

Kevin O’Leary of ‘Shark Tank’: Institutional investors want to wager on cannabis – just not yet

Big institutional investors are sitting on billions of dollars they’d like to pump into the marijuana industry, but that’s not likely to happen as long as cannabis remains illegal in the eyes of Uncle Sam, according to investment mogul Kevin O’Leary. “The amount of capital that wants to come into this space is unprecedented,” said […]

Read More

Exclusive: US marijuana sales may reach $10 billion this year, $22 billion by 2022

Retail sales of medical and recreational cannabis in the United States are expected to hit $8 billion-$10 billion this year – a nearly 50% increase from 2017 – and rise as high as $22 billion by 2022. That’s according to exclusive projections from the 2018 edition of the Marijuana Business Factbook released Wednesday at the […]

Read More

McLellan calls on Canadian Senate to avoid ‘undue partisanship’ to get around rec cannabis delay

The former chair of Canada’s federal task force on cannabis legalization is calling on senators to avoid “undue partisan activity” as the bill faces the potential of a delay over contentious amendments that are under consideration. The Senate has every right to consider the Cannabis Act rigorously, Anne McLellan told Marijuana Business Daily. “But I’m hoping that partisanship […]

Read More

Escape from Los Angeles: Marijuana businesses leave as city struggles to roll out legal market

Marijuana companies are fleeing Los Angeles, a setback for what is arguably the biggest cannabis market in the world. Industry executives blame city officials and their inability to approve business licenses in a timely manner. Just ask Kenny Morrison. A decade after founding his cannabis edibles business and finding success in the iconic Venice Beach area of […]

Read More

Week in Review: SBA says no to cannabis, Maine advances rec MJ & Scotts Miracle-Gro shrinks

The U.S. Small Business Administration bars banks from issuing SBA-backed loans to marijuana- and hemp-related companies, Maine lawmakers override a veto of key adult-use legislation, and Scotts Miracle-Gro consolidates its cannabis operations. Here’s a closer look at some notable developments in the cannabis industry over the past week. SBA shuts off the spigot Small businesses […]

Read More

Louisiana medical marijuana program advances, but progress slow and questions swirl over future

Louisiana is preparing to launch its medical marijuana program later this year, although concerns persist about its long-term viability because of current limits on the number of MMJ products and treatable conditions, among other factors. The state Board of Pharmacy recently awarded permits to nine medical pharmacies statewide to dispense MMJ products, and two state universities […]

Read More